{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:40:01Z","timestamp":1761093601287,"version":"build-2065373602"},"reference-count":26,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"vor","delay-in-days":4491,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[1999,10]]},"abstract":"<jats:p>A 41\u2010year\u2010old woman was seen in no acute distress with an infected ventriculoperitoneal shunt. She underwent several revisions of the shunt but was readmitted to the hospital with nausea, vomiting, and neurologic sequelae. Results of spinal fluid analysis were white blood cells 68\/mm<jats:sup>3<\/jats:sup> (25% neutrophils), glucose less than 20 mg\/dl, and protein 513 mg\/dl. Cerebrospinal fluid, aerobic and anaerobic, and blood cultures were negative. Three weeks later the patient suffered a seizure and was prescribed antitubercular agents for a presumed diagnosis of tubercular meningitis. One week later, chest wound culture from her first visit suggested <jats:italic>Mycobacterium tuberculosis<\/jats:italic>, which was confirmed by DNA probe; cerebrospinal fluid culture eventually grew the organism. The patient fared well once she received antituberculosis agents. The time between first contact and treatment in the hospital delayed therapy.<\/jats:p>","DOI":"10.1592\/phco.19.15.1167.30575","type":"journal-article","created":{"date-parts":[[2004,4,26]],"date-time":"2004-04-26T10:03:10Z","timestamp":1082973790000},"page":"1167-1172","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Diagnosis and Treatment of Complicated Tubercular Meningitis"],"prefix":"10.1002","volume":"19","author":[{"given":"Julia J.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Destache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan H.","family":"Fruin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicki A.","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.9.1775"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/148.3.650"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.47.8.577"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ajcp\/95.3.418","article-title":"Issues in cerebrospinal fluid management","volume":"95","author":"Albright RE","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0303-8467(92)90109-G"},{"key":"e_1_2_1_7_2","first-page":"497","article-title":"Computed tomography and magnetic resonance imaging of tuberculous meningitis","volume":"93","author":"Shanley DJ","year":"1993","journal-title":"J Am Optom Assoc"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1183\/09031936.93.05070891","article-title":"Intraventricular rifampicin in severe tuberculous meningo\u2010encephalitis","volume":"5","author":"Vincken W.","year":"1992","journal-title":"Eur Respir J"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)31045-8"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199039020-00006"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.54.6.499"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00588250"},{"key":"e_1_2_1_13_2","first-page":"153","article-title":"Atypical presentations of tuberculous meningitis\u2014a case report","volume":"48","author":"Wang P.","year":"1991","journal-title":"Clin Med J (Taipei)"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90542-X"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/6.2.214"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-198605000-00015"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1979.03290290032021"},{"issue":"7","key":"e_1_2_1_18_2","first-page":"51669","article-title":"Drug delivery to the central nervous system: general principles and relevance to therapy for infections of the central nervous system","volume":"11","author":"Scheld WM","year":"1989","journal-title":"Rev Infect Dis"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1542\/peds.89.2.247","article-title":"Cerebrospinal fluid isoniazid concentrations in children with tuberculous meningitis: the influence of dosage and acetylation status","volume":"89","author":"Donald PR","year":"1992","journal-title":"Pediatrics"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.294.6567.284"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.61.7.629"},{"key":"e_1_2_1_22_2","first-page":"235","article-title":"Cerebrospinal fluid and serum levels of pyrazinamide and rifampicin in patients with tuberculous meningitis","volume":"42","author":"Woo J.","year":"1987","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1991.2"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/515543"},{"key":"e_1_2_1_25_2","first-page":"175","volume-title":"Tuberculosis and nontuberculosis mycobacterial infections","author":"Kasik J.","year":"1999"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198506000-00025"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1001\/archinte.1997.00440420085007","article-title":"Update on rifampin drug interactions. III","volume":"157","author":"Strayhorn V.","year":"1997","journal-title":"Arch Intern Med"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.19.15.1167.30575","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.19.15.1167.30575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:10:04Z","timestamp":1761048604000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.19.15.1167.30575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1999,10]]}},"alternative-id":["10.1592\/phco.19.15.1167.30575"],"URL":"https:\/\/doi.org\/10.1592\/phco.19.15.1167.30575","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[1999,10]]},"assertion":[{"value":"2012-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}